The Neurological Field Continues to Update

In recent years, there has been tremendous growth in new diagnostic information, pharmacological and neurosurgical treatments for neurological disease, as well as a greater understanding of brain function. Our news section informs you of ongoing topics with a potential worldwide influence. In addition to this section, we inform through our social media platforms to keep connect with our member more easier than before. 

 WFN FaceBook twitter linkedin round blue

Our subcategories on News include:

  • World Federation of Neurology News
    We inform you on our projects and activities, the journal updates, the WFN committee update and more...
  • Neurology News
    Update on interesting news and current activities with worldwide scope. From the history of neurology through the modern technology that shape neurology nowadays.

World Federation of Neurology News

Pinned

28 Jun 2024

WHO IGAP Toolkit to launch on 8th July

On July 8th, the WHO will present the toolkit for the IGAP. The development of the Tool Kit has been supported by the World Federation of Neurology.

28 Jun 2024

eNeurologicalSci (eNS) June 2024 issue

The WFN June 2024 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 35 is now available online.

14 Jun 2024

WFN launches improved e-Learning Hub

WFN is pleased to announce launch of novel e-Learning Hub offering free access video resource directory.

Neurology News

28 Jun 2024

eNeurologicalSci (eNS) June 2024 issue

The WFN June 2024 issue of the OPEN ACCESS journal eNeurologicalSci Vol. 35 is now available online.

15 Jun 2024

Typical and atypical MRI abnormalities in Wernicke's encephalopathy:Correlation with blood vitamin B1 levels [Editors Choice]

Clinical features of Wernicke's encephalopathy (WE) confirmed strictly through the low blood vitamin B1 (VB1) levels are limited. This study aimed to analyse magnetic resonance imaging (MRI) findings, and clinical characteristics, in patients with WE who have confirmed low blood VB1 levels.

15 Jun 2024

Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course of the disease

Multiple analyses have demonstrated that non-adherence to medication is associated with suboptimal health outcomes. However, the reasons contributing to non-adherence are complex and varied.

 

International Meetings & Events

There are no events to show.